Prof. Kwabena Frimpong-Manso Opuni appointed Acting CEO of FDA

The Food and Drugs Authority (FDA) has announced the appointment of Professor Kwabena Frimpong-Manso Opuni as its new Acting Chief Executive Officer, effective Monday, July 14, 2025.

Prof. Opuni, who previously served as the Board Chairman of the FDA, takes over from Dr. Delese Mimi Darko, who has led the Authority since 2017.

Dr. Darko was recently appointed as the Director General of the Africa Medicines Agency (AMA), marking a significant step forward for Ghana’s leadership in continental health regulation.

A statement issued by the FDA congratulated Prof. Opuni on his new role and expressed confidence in his ability to lead the institution in fulfilling its core mandate of ensuring public health and safety.

“The FDA extends its warmest congratulations to Prof. Opuni on his appointment and looks forward to his leadership in advancing the Authority’s mission,” the statement read.

Prof. Opuni is widely respected in the medical and regulatory community and is expected to bring a wealth of experience and continuity to the Authority during this transition period.

Story by: Joshua Kwabena Smith